Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Avidity Biosciences Inc (RNA)
NASDAQ:RNA
Avidity Biosciences (RNA) Stock Price & Analysis
513 Followers
RNA Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$4.83 - $42.00
Previous Close$41.28
Volume1.38M
Average Volume (3M)1.46M
Market Cap
$3.95B
Enterprise Value$3.04B
Total Cash (Recent Filing)$915.87M
Total Debt (Recent Filing)$9.15M
Price to Earnings (P/E)―
Beta1.09
Next Earnings
Aug 06, 2024EPS Estimate
-$0.84Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.95
Shares Outstanding95,636,748
10 Day Avg. Volume3,258,776
30 Day Avg. Volume1,458,362
Standard Deviation0.23
R-Squared0.03
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)7.45
Price to Sales (P/S)1052.73
Price to Cash Flow (P/CF)56.50
P/FCF Ratio59.60
Enterprise Value/Market CapN/A
Enterprise Value/Revenue279.78
Enterprise Value/Gross Profit318.11
Enterprise Value/Ebitda-12.34
Forecast
1Y Price Target
$52.57Price Target Upside35.49% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering7
Avidity Biosciences News
Bulls Say, Bears Say
Bulls Say
Management TeamStrong management team with a proven track record of success.
Product InnovationThe product innovation pipeline is expected to drive future growth.
Revenue GrowthThe company has shown consistent revenue growth over the past quarters.
Bears Say
CompetitionConcerns have been raised about increasing competition in the market.
RegulationPotential regulatory changes could negatively impact the company's operations.
ResearchThere are gaps in knowledge for FSHD, questions surrounding DUX4 downstream gene expression and whether it can be measured reliably in clinical trials.
---
Ownership Overview
11.72% Insiders
24.29% Mutual Funds
51.36% Other Institutional Investors
12.64% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
RNA FAQ
What was Avidity Biosciences Inc’s price range in the past 12 months?
Avidity Biosciences Inc lowest stock price was $4.83 and its highest was $42.00 in the past 12 months.
What is Avidity Biosciences Inc’s market cap?
Currently, no data Available
When is Avidity Biosciences Inc’s upcoming earnings report date?
Avidity Biosciences Inc’s upcoming earnings report date is Aug 06, 2024 which is in 34 days.
How were Avidity Biosciences Inc’s earnings last quarter?
Avidity Biosciences Inc released its earnings results on May 09, 2024. The company reported -$0.79 earnings per share for the quarter, beating the consensus estimate of -$0.796 by $0.006.
Is Avidity Biosciences Inc overvalued?
According to Wall Street analysts Avidity Biosciences Inc’s price is currently Undervalued.
Does Avidity Biosciences Inc pay dividends?
Avidity Biosciences Inc does not currently pay dividends.
What is Avidity Biosciences Inc’s EPS estimate?
Avidity Biosciences Inc’s EPS estimate is -$0.84.
How many shares outstanding does Avidity Biosciences Inc have?
Avidity Biosciences Inc has 95,636,750 shares outstanding.
What happened to Avidity Biosciences Inc’s price movement after its last earnings report?
Avidity Biosciences Inc reported an EPS of -$0.79 in its last earnings report, beating expectations of -$0.796. Following the earnings report the stock price went down -4.207%.
Which hedge fund is a major shareholder of Avidity Biosciences Inc?
Among the largest hedge funds holding Avidity Biosciences Inc’s share is RA Capital Management. It holds Avidity Biosciences Inc’s shares valued at 84M.
---
Avidity Biosciences Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$52.57 (35.49% Upside)
$52.57 (35.49% Upside)
Blogger Sentiment
Bullish
RNA Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 1.9M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $1.3M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 2.2%
Last 30 Days ▲ 18.8%
Last 30 Days ▲ 18.8%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
272.22%
12-Months-Change
Fundamentals
Return on Equity
-32.91%
Trailing 12-Months
Asset Growth
54.97%
Trailing 12-Months
Company Description
Avidity Biosciences Inc
Avidity Biosciences Inc is a bio-technology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product candidate AOC 1001, is designed to treat a rare monogenic muscle disease.
---
RNA Stock 12 Month Forecast
Average Price Target
$52.57
▲(35.49% Upside)
Technical Analysis
Best Analysts Covering RNA
1 Year
1 Year Success Rate
12/17 ratings generated profit
1 Year Average Return
+170.95%
assigned a buy rating 20 days ago
Copying Yanan Zhu's trades and holding each position for 1 Year would result in 70.59% of your transactions generating a profit, with an average return of +170.95% per trade.
---